1. West NR, McCuaig S, Franchini F, Powrie F (2015): Emerging cytokine networks in colorectal cancer. Nat Rev Immunol 15: 615-629.
2.
Lasry A, Zinger A, Ben-Neriah Y (2016): Inflammatory networks underlying colorectal cancer. Nat Immunol 17: 230-240.
3.
Jochem C, Leitzmann M (2016): Obesity and colorectal cancer. Recent Results Cancer Res 208: 17-41.
4.
Kadowaki T, Yamauchi T (2005): Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451.
5.
Carpéné C, Dray C, Attané C, et al. (2007): Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 63: 359-373.
6.
Boucher J, Masri B, Daviaud D, et al. (2005): Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146: 1764-1771.
7.
Wysocka MB, Pietraszek-Gremplewicz K, Nowak D (2018): The role of apelin in cardiovascular diseases, obesity and cancer. Front Physiol 9: 557-566.
8.
Lin ZY, Chuang WL (2013): Hepatocellular carcinoma cells cause different responses in expressions of cancer-promoting genes in different cancer-associated fibroblasts. Kaohsiung J Med Sci 29: 312-318.
9.
Lv D, Li L, Lu Q, et al. (2016): PAK1-cofilin phosphorylation mediates human lung adenocarcinoma cells migration induced by apelin-13. Clin Exp Pharmacol Physiol 43: 569-579.
10.
Picault FX, Chaves Almagro C, Projetti F, et al. (2014): Tumour co expression of apelin and its receptor is the basis of an autocrine loop involved in the growth of colon adenocarcinomas. Eur J Cancer 50: 663 674.
11.
Altinkaya SO, Nergiz S, Küçük M, Yüksel H (2015): Apelin levels are higher in obese patients with endometrial cancer. J Obstet Gynaecol Res 41: 294-300.
12.
Unal I, Khiavi IR, Tasar GE, et al. (2020): Tumor apelin immunoreactivity is correlated with body mass index in ovarian high grade serous carcinoma. Biotech Histochem 95: 27-36.
13.
Çelik FS, Güneş CE, Yavuz E, Kurar E (2023): Apelin triggers macrophage polarization to M2 type in head and neck cancer. Immunobiology 228: 152353.
14.
Kawai T, Akira S (2010): The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
15.
Salmaninejad A, Valilou SF, Soltani A, et al. (2019): Tumor-associated macrophages: role in cancer development and therapeutic implications. Cell Oncol 42: 591-608.
16.
Podgórska M, Diakowska D, Pietraszek Gremplewicz K, et al. (2019): Evaluation of apelin and apelin receptor level in the primary tumor and serum of colorectal cancer patients. J Clin Med 8: 1513.
17.
Xin Q, Cheng B, Pan Y, et al. (2015): Neuroprotective effects of apelin-13 on experimental ischemic stroke through suppression of inflammation. Peptides 63: 55-62.
18.
Cui J, Ren Z, Zou W, Jiang Y (2017): miR-497 accelerates oxidized low-density lipoprotein-induced lipid accumulation in macrophages by repressing the expression of apelin. Cell Biol Int 41: 1012-1019.
19.
Massague J (2012): TGFb signaling in context. Nat Rev Mol Cell Biol 13: 616-630.
20.
Cao W, Peters JH, Nieman D, et al. (2015): Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro. Br J Cancer 113: 738-746.
21.
Barbera-Guillem E, Nyhus JK, Wolford CC, et al. (2022): Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 62: 7042-7049.
22.
Qian BZ, Li J, Zhang H, et al. (2011): CCL2 recruits inflammatory monocytes to facilitate breast- tumour metastasis. Nature 475: 222-225.
23.
Allavena P, Chieppa M, Monti P, Piemonti L (2004): From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. Crit Rev Immunol 24: 179-192.
24.
Saiki H, Hayashi Y, Yoshii S, et al. (2023): The apelin apelin receptor signaling pathway in fibroblasts is involved in tumor growth via p53 expression of cancer cells. Int J Oncol 63: 139.
